Effect of Pay for Performance on Hypertension in the United Kingdom

Aggressive blood pressure reduction and renin–angiotensin system blockade in chronic kidney disease: time for re-evaluation?

Blood Pressure Goals: How Low Is Safe in CKD?

The Impact of APOL1 on Chronic Kidney Disease and Hypertension.

Risk for Incident Renal Dialysis in a Managed Care Population

Hypertension in Hemodialysis Patients: The Role of Antihypertensive Medications

Ambulatory Blood Pressure Monitoring: Profiles in Chronic Kidney Disease Patients and Utility in Management.

Relation of Baseline Systolic Blood Pressure and Long-Term Outcomes in Ambulatory Patients With Chronic Mild to Moderate Heart Failure

Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?

Hypertension in Moderate-to-Severe Nondiabetic CKD Patients

Blood Pressure Goals and Treatment in Pregnant Patients With Chronic Kidney Disease

Complications of Progression of CKD

Management of Hypertension in Patients With Diabetic Kidney Disease: Summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2021

Adherence to Guideline-Recommended Adjunctive Heart Failure Therapies Among Outpatient Cardiology Practices (Findings from IMPROVE HF)

Lowering Blood Pressure to Lower the Risk of Cardiovascular Events in CKD

Apolipoprotein L1 gene variants associate with prevalent kidney but not prevalent cardiovascular disease in the Systolic Blood Pressure Intervention Trial